EV/EBITDA
-1.51
+0.02+1.31%
Sat, 22 Feb 2025 00:53:15 GMT
Summary
- As of February 23, 2025, IPA EV/EBITDA is -1.51, with a rise of +0.02 (+1.31%) during the most recent trading day.
- Over the past year, IPA EV/EBITDA has increased by +5.80 (+79.34%).
- IPA EV/EBITDA is now -100.63% below its all-time high of 240.79.
Performance
IPA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
IPA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.3% | -1.6% | -2.4% |
| 1 m1 month | +6.2% | -6.6% | -38.8% |
| 3 m3 months | -39.8% | +39.8% | +16.9% |
| 6 m6 months | +19.3% | -18.6% | -56.6% |
| ytdytd | -20.8% | +20.7% | -8.1% |
| 1 y1 year | +79.3% | -48.1% | -77.8% |
| 5 y5 years | +92.0% | -24.5% | -84.6% |
IPA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -16.1% | -1.82 | +17.0% | |
| 3 m | 3-month | -1.08 | -39.8% | -1.82 | +17.0% |
| 6 m | 6-month | -1.08 | -39.8% | -1.87 | +19.3% |
| 1 y | 1-year | -1.08 | -39.8% | -7.83 | +80.7% |
| 3 y | 3-year | -1.08 | -39.8% | -13.12 | +88.5% |
| 5 y | 5-year | 240.79 | -100.6% | -715.32 | +99.8% |
| alltime | all time | 240.79 | -100.6% | -715.32 | +99.8% |
ImmunoPrecise Antibodies EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.51(+20.8%) |
| 2024 | -1.25(-79.8%) |
| 2023 | -6.20(-21.3%) |
| 2022 | -7.88(-26.0%) |
| 2021 | -10.65(-107.5%) |
| 2020 | 142.35(-1363.1%) |
| 2019 | -11.27(+16.4%) |
| 2018 | -9.68(+166.7%) |
| 2017 | -3.63(-153.5%) |
| 2016 | 6.78(-347.4%) |
| 2015 | -2.74(-35.2%) |
| 2014 | -4.23(-321.5%) |
| Date | Value |
|---|---|
| 2013 | 1.91(-190.1%) |
| 2012 | -2.12(-18.5%) |
| 2011 | -2.60(+504.7%) |
| 2010 | -0.43(-85.9%) |
| 2009 | -3.04(+121.9%) |
| 2008 | -1.37(-86.2%) |
| 2007 | -9.96(-56.9%) |
| 2006 | -23.11(-11.0%) |
| 2005 | -25.98(-22.5%) |
| 2004 | -33.53(-31.2%) |
| 2003 | -48.75(+268.2%) |
| 2002 | -13.24 |
FAQ
- What is ImmunoPrecise Antibodies EV/EBITDA?
- What is the all time high EV/EBITDA for ImmunoPrecise Antibodies?
- What is IPA EV/EBITDA year-to-date change?
- What is ImmunoPrecise Antibodies EV/EBITDA year-on-year change?
What is ImmunoPrecise Antibodies EV/EBITDA?
The current EV/EBITDA of IPA is -1.51
What is the all time high EV/EBITDA for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high EV/EBITDA is 240.79
What is IPA EV/EBITDA year-to-date change?
ImmunoPrecise Antibodies EV/EBITDA has changed by -0.26 (-20.80%) since the beginning of the year
What is ImmunoPrecise Antibodies EV/EBITDA year-on-year change?
Over the past year, IPA EV/EBITDA has changed by +5.80 (+79.34%)